In addition, we investigated the effects of stem cell-mediated gene delivery of IFN-β in combination with systemic treatment with low doses of cisplatin in a canine malignant melanoma xenograft model; we found that this treatment combination resulted in a significant additive anti-tumor effect. The gene discussed is IFNB1; the disease is neoplasm.